Cargando…
Circulating Small EVs miRNAs as Predictors of Pathological Response to Neo-Adjuvant Therapy in Breast Cancer Patients
Neo-adjuvant therapy (NAT) is increasingly used in the clinic for the treatment of breast cancer (BC). Pathological response to NAT has been associated with improved patients’ survival; however, the current techniques employed for assessing the tumor response have significant limitations. Small EVs...
Autores principales: | Baldasici, Oana, Balacescu, Loredana, Cruceriu, Daniel, Roman, Andrei, Lisencu, Carmen, Fetica, Bogdan, Visan, Simona, Cismaru, Andrei, Jurj, Ancuta, Barbu-Tudoran, Lucian, Pileczki, Valentina, Vlase, Laurian, Tudoran, Oana, Balacescu, Ovidiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604084/ https://www.ncbi.nlm.nih.gov/pubmed/36293478 http://dx.doi.org/10.3390/ijms232012625 |
Ejemplares similares
-
Breast Cancer-Delivered Exosomal miRNA as Liquid Biopsy Biomarkers for Metastasis Prediction: A Focus on Translational Research with Clinical Applicability
por: Baldasici, Oana, et al.
Publicado: (2022) -
Baseline blood immunological profiling differentiates between Her2–breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response
por: Tudoran, Oana, et al.
Publicado: (2015) -
The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the Pathological Response of Breast Cancer Patients to Neoadjuvant Therapy
por: Lisencu, Lorena Alexandra, et al.
Publicado: (2022) -
Blood Genome-Wide Transcriptional Profiles of HER2 Negative Breast Cancers Patients
por: Balacescu, Ovidiu, et al.
Publicado: (2016) -
Differential Peripheral Blood Gene Expression Profile Based on Her2 Expression on Primary Tumors of Breast Cancer Patients
por: Tudoran, Oana, et al.
Publicado: (2014)